Mobile Computing, Applications, and Services. 5th International Conference, MobiCASE 2013, Paris, France, November 7-8, 2013, Revised Selected Papers

Research Article

Design and Evaluation of a Medication Application for People with Parkinson’s Disease

Download
478 downloads
  • @INPROCEEDINGS{10.1007/978-3-319-05452-0_22,
        author={Ana Barros and Jo\"{a}o Cevada and \'{A}ngels Bay\^{e}s and Sheila Alcaine and Berta Mestre},
        title={Design and Evaluation of a Medication Application for People with Parkinson’s Disease},
        proceedings={Mobile Computing, Applications, and Services. 5th International Conference, MobiCASE 2013, Paris, France, November 7-8, 2013, Revised Selected Papers},
        proceedings_a={MOBICASE},
        year={2014},
        month={6},
        keywords={Smartphone Usability tests Parkinson’s disease Gestures},
        doi={10.1007/978-3-319-05452-0_22}
    }
    
  • Ana Barros
    João Cevada
    Àngels Bayés
    Sheila Alcaine
    Berta Mestre
    Year: 2014
    Design and Evaluation of a Medication Application for People with Parkinson’s Disease
    MOBICASE
    Springer
    DOI: 10.1007/978-3-319-05452-0_22
Ana Barros1,*, João Cevada1,*, Àngels Bayés2, Sheila Alcaine2, Berta Mestre2,*
  • 1: Fraunhofer Portugal AICOS
  • 2: Centro Médico Teknon, Unitat de Parkinson i Trastorns del Moviment
*Contact email: ana.barros@fraunhofer.pt, joao.cevada@fraunhofer.pt, 11741abr@comb.cat

Abstract

Smartphones may allow disease self-management, which is relevant for people with Parkinson’s Disease (PD) in need of frequent medication adjustments. Yet, there is little data on the interaction of people with PD with smartphones. We describe the processes of the design and usability evaluation of a smartphone medication application for PD. Results show that participants with PD were generally able to successfully interact with the tailored user interfaces (UI), and grasp navigation and organization principles designed into the application. The paper lists issues for UI improvement and further testing.